Radiodermatitis; Acute
6
0
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
10 treatments under study, led by Photobiomodulation Therapy
Research Leaders
8 sponsors active, led by University of Nove de Julho
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (6)
Retrospective Observational Study on the Use of Advanced Bacterial-binding Dressings (DACC-coated Hydrogel Dressings) in Radiodermatitis
A Study of GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer
Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients
The Use of Photobiomodulation in the Management of Radiodermatitis in Head and Neck Cancer Patients
The Use of Photobiomodulation in the Management of Radiodermatitis in Patients in Palliative Care. A Prospective Study.
Novel Skin Care Product for the Management of Acute Radiodermatitis
Research Network
Common Treatments
- Photobiomodulation Therapy2
- Standard Institutional Skin Care1
- Radiation Therapy1
- Gr1014cg 241
- Betamethasone Valerate1
Active Sponsors
- University of Nove de Julho2
- Cairo University1
- Excelya1
- Graegis Pharmaceuticals Limited1
- Hasselt University1
Top Investigators
University of Nove de Julho
Jessa ziekenhuis VZW
University of Nove de Julho
Related Conditions
- Radiotherapy Side Effect2
- Palliative Care1
- Radiation Dermatitis1
- Head And Neck Cancer1
- Cancer Patients1